Our mission is to improve cancer care. To achieve this, we focus on innovations in molecular diagnostics and collaborate with partners who share the same mission.
Developing innovative molecular analyses
The complete DNA test developed by Hartwig is called OncoAct. After the complete DNA test has been performed on patients with cancer, we analyze the patient’s molecular and treatment information. Platinum is the heart of the complete DNA test. We have made this analysis software tool available to other users on Google Platform, as well.
To ensure that as many patients as possible can benefit from this technology, we have made this software available for research and diagnostics free of charge via GitHub. To this end, we collaborate with research groups in Australia, Europe and the United States.
Collecting information about the patient and the tumor
We store the genetic and clinical data generated during the diagnostic procedure in the Hartwig Medical Database. This database enables research into improved treatments for the patients of tomorrow. By systematically identifying detailed molecular characteristics of tumors in large groups of patients, we can increase our knowledge of tumor origins and development and improve the effectiveness of treatments.
Integrating information and knowledge with treatment outcomes to accelerate scientific research into cancer
We collaborate with all relevant stakeholders and organizations.
We want to extract the maximum amount of information from the patient’s tumor. This DNA test is the The complete DNA test is the best available tool to extract the maximum amount of information from the patient’s tumor. We only need one tissue sample with sufficient tumor cells. We literally analyze the entire genome, including parts of the DNA that show mutations of which we don’t yet know the importance. This test is tumor-independent and future-proof. These are the two most important advantages of WGS.